Form 483

Meta Labs Pharmaceuticals, LLC Form 483, 2012-07-20

FDA issued a Form 483 to Meta Labs Pharmaceuticals, LLC on 2012-07-20 with 9 public-safe observations.

483· Form 483 issued9 observations

Meta Labs Pharmaceuticals, LLC · Roswell, United States · Issued July 20, 2012

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Jul 2012
21 CFR 111.14(b)(1)

Personnel - records - written procedures

Cited by Seneca D Toms

20 Jul 2012
21 CFR 111.16

Written procedures - cleaning

Cited by Seneca D Toms

20 Jul 2012
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Seneca D Toms

20 Jul 2012
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Seneca D Toms

20 Jul 2012
21 CFR 111.140(b)(1)

Records - quality control operations; responsibilities

Cited by Seneca D Toms

Inspected site

MLMeta Labs Pharmaceuticals, LLCRoswell, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.14(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.140(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.16Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(a)Cited across public-safe Form 483 observations1x
21 CFR 111.375(b)Cited across public-safe Form 483 observations1x
21 CFR 111.570(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere